The 2022-2023 influenza (flu) season epidemic is off to an early start in the European region as concerns over Respiratory syncytial virus (RSV) rise and COVID-19 is still being a threat.
As of 15 July 2022, 401 confirmed (n=399) and probable (n=2) cases of monophasic S. Typhimurium have been identified in the EU/EEA and the United Kingdom.
ECDC provides support to EU/EEA countries in monitoring their progress towards the hepatitis elimination targets and has just published a report based on the second data collection.